Key Financial Data Of Group

Delta-Fly Pharma, Inc. - Filing #7713831

Concept As at
2018-12-31
2018-10-01 to
2018-12-31
2018-04-01 to
2018-12-31
As at
2018-03-31
2017-04-01 to
2018-03-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-501,880,000 JPY
-244,505,000 JPY
Net assets
3,674,335,000 JPY
822,493,000 JPY
Total assets
3,721,295,000 JPY
864,145,000 JPY
Basic earnings (loss) per share
-52.75
-131.63
-71.20
Diluted earnings per share
Equity-to-asset ratio
0.987 xbrli:pure
0.952 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.